Related Experiment Video

Updated: Jun 23, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

Antioxidant gene therapy for cardiovascular disease: current status and future perspectives

Anna-Liisa Levonen1, Elisa Vähäkangas, Jonna K Koponen

  • 1Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Finland. Anna-Liisa.Levonen@uku.fi

Circulation
|April 23, 2008
PubMed

Insights

Antioxidant gene therapy shows promise for treating cardiovascular diseases by combating excessive reactive oxygen species. This review explores successful studies, current limitations, and future directions for this therapeutic approach.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Genetics

Background:

  • Excessive reactive oxygen species (ROS) production is linked to cardiovascular pathologies like hypertension, atherosclerosis, and myocardial infarction.
  • Natural antioxidant defenses can be overwhelmed, creating a need for therapeutic interventions.
  • Antioxidant therapies offer a potential strategy to restore balance when endogenous defenses are insufficient.

Purpose of the Study:

  • To review the successful application of antioxidant gene therapy in treating cardiovascular diseases.
  • To identify current limitations hindering the efficacy of antioxidant gene therapy.
  • To propose future therapeutic targets and methodological advancements for improved outcomes.

Main Methods:

  • Literature review of studies utilizing antioxidant gene therapy for cardiovascular conditions.
  • Analysis of successful treatment outcomes and identified challenges.
  • Exploration of emerging therapeutic targets and innovative methodologies.

Main Results:

  • Antioxidant gene therapy has demonstrated success in preclinical and clinical settings for various cardiovascular diseases.
  • Key limitations include delivery methods, immune responses, and long-term efficacy.
  • Emerging strategies focus on targeted gene delivery and novel antioxidant pathways.

Conclusions:

  • Antioxidant gene therapy represents a promising therapeutic avenue for cardiovascular diseases driven by oxidative stress.
  • Overcoming current limitations is crucial for widespread clinical adoption.
  • Future research should focus on refining delivery systems and identifying new therapeutic targets to enhance treatment efficacy.

More Related Videos

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart06:07

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.